"Services include Cancer Services, Children's Services, Emergency Services, Neuroscience Services, Orthopedics, Weight Loss Surgery, Women's Services and more."

During the past decade, Memorial Hermann The Woodlands Hospital conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 3 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Memorial Hermann The Woodlands Hospital" #1 sponsor was "Abbott Medical Devices" with 4 trials, followed by "Alliance for Clinical Trials in Oncology" with 2 trials sponsored, "National Cancer Institute (NCI)" with 2 trials sponsored, "Columbia University" with 1 trials sponsored and "NovoCure Ltd." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Memorial Hermann The Woodlands Hospital" #1 collaborator was "Genentech, Inc." with 2 trials as a collaborator, "National Cancer Institute (NCI)" with 2 trials as a collaborator, "Brain Science Foundation" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Erlanger Medical Center" with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Memorial Hermann The Woodlands Hospital" are "Bradycardia" (2 trials), "Cardiac Rhythm Disorder" (2 trials), "Recurrent Breast Carcinoma" (2 trials), "Acute Respiratory Failure" (1 trials) and "Advanced Malignant Solid Neoplasm" (1 trials). Many other conditions were trialed in "Memorial Hermann The Woodlands Hospital" in a lesser frequency.

Most popular intervention types in "Memorial Hermann The Woodlands Hospital" are "Device" (6 trials), "Drug" (6 trials), "Biological" (2 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abemaciclib" (2 trials), "Capivasertib" (2 trials), "Laboratory Biomarker Analysis" (2 trials), "Trastuzumab" (2 trials) and "Vismodegib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Memorial Hermann The Woodlands Hospital" are 10 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Memorial Hermann The Woodlands Hospital". undefined are not yet recruiting, 3 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Memorial Hermann The Woodlands Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Memorial Hermann The Woodlands Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".